PIK3CA and breast carcinoma: The luminal-type breast cancer cell lines used in our study (MCF7 and BT474 cells) had mutations in PIK3CA [19, 36], whereas TNBC cell lines (MDA-MB-231 and Hs 578T cells) had wild-type PIK3CA.